Europe Contrast Injector Systems Market Size to register a growth of 7.5% CAGR

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Europe Contrast Injector Systems Market, published by KBV research, the Europe Contrast Injector Systems Market would witness market growth of 7.5% CAGR during the forecast period (2018 – 2024).

The Germany market would dominate the Europe Radiology Market by 2024, growing at a CAGR of 5.9 % during the forecast period. The UK market is expected to witness a CAGR of 5.6% during (2018 - 2024). Additionally, The France market is expected to witness a CAGR of 8% during (2018 - 2024).

The Consumables market dominated the Europe Contrast Injector Systems Market by Product in 2017. The Injector Systems market is expected to witness a CAGR of 7.9% during (2018 - 2024).

The Hospitals market dominated the France Contrast Injector Systems Market by End User in 2017, and would achieve a market value of $20.1 million by 2024. The Diagnostics Centers market is expected to witness a CAGR of 8.2% during (2018 - 2024).

Full Report:https://www.kbvresearch.com/europe-contrast-injector-systems-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles Bayer AG, Angiodynamics Inc., GE Healthcare (A Healthcare Division of GE Company), Medtron AG, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. Kg, Vivid Imaging and Guerbet Group.